KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2025)

Historic Treasury Shares for Xenon Pharmaceuticals (XENE) over the last 2 years, with Q3 2025 value amounting to $313382.0.

  • Xenon Pharmaceuticals' Treasury Shares rose 4922.95% to $313382.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $313382.0, marking a year-over-year increase of 4922.95%. This contributed to the annual value of $210000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Xenon Pharmaceuticals' Treasury Shares is $313382.0, which was up 4922.95% from $316957.0 recorded in Q2 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Treasury Shares peaked at $316957.0 during Q2 2025, and registered a low of $192000.0 during Q1 2024.